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NeuroprotectionADP-speciﬁc P2Y13 receptor constitutes one of the most recently identiﬁed nucleotide receptor and the under-
standing of their physiological role is currently under investigation. Cerebellar astrocytes and granule neurons
provide excellent models to study P2Y13 expression and function since the ﬁrst identiﬁcation of ADP-evoked
calcium responses not attributable to the related P2Y1 receptor was performed in these cell populations. In this
regard, all responses induced by ADP analogues in astrocytes resulted to be Gi-coupled activities mediated by
P2Y13 instead of P2Y1 receptors. Similarly, both glycogen synthase kinase-3 (GSK3) and ERK1/2 signaling trig-
gered by 2MeSADP in cerebellar granule neurons were also dependent on Gi-coupled receptors, and mediated
by PI3K activity. In granule neurons, P2Y13 receptor was speciﬁcally coupled to the main neuronal survival
PI3K/Akt-cascade targeting GSK3 phosphorylation. GSK3 inhibition led to nuclear translocation of transcriptional
targets, including β-catenin and Nrf2. The activation of the Nrf2/heme oxygenase-1 (HO-1) axis was responsible
for the prosurvival effect against oxidative stress. In addition, P2Y13-mediated ERK1/2 signaling in granule neu-
rons also triggered activation of transcription factors, such as CREB, which underlined the antiapoptotic action
against glutamate-induced excitotoxicity. Finally, a novel signaling mechanism has been recently described for
a P2Y13 receptor in granule neurons that involved the expression of a dual protein phosphatase, DUSP2. This ac-
tivity contributed to regulate MAPK activation after genotoxic stress. In conclusion, P2Y13 receptors harbored in
cerebellar astrocytes and granule neurons exhibit speciﬁc signaling properties that link them to specialized func-
tions at the level of neuroprotection and trophic activity in both cerebellar cell populations.
© 2015 Pérez-Sen et al. Published by Elsevier B.V. on behalf of the Research Network of Computational and
Structural Biotechnology. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Contents1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
2. Presence of Functional P2Y13 Receptors in Rat Cerebellar Astrocytes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
3. P2Y13 Receptor Expression in Rat Cerebellar Granule Neurons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
4. P2Y13 Receptors are Coupled to GSK3 Signaling in Granule Neurons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
4.1. P2Y13 Receptor Mediated Activation of the Nrf-2/HO-1 Axis in Granule Neurons . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
5. P2Y13 Receptor Mediated Signaling Through ERK1/2-MAPK in Granule Neurons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
5.1. Dual Speciﬁcity Protein Phosphatase 2, DUSP2, is an Intracellular Target of P2Y13 Receptor in Granule Neurons . . . . . . . . . . . . . . 165
6. Summary and Outlook . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166
Conﬂict of Interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 167
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 167
References. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 167ímica y Biología Molecular IV,
drid, Avda Puerta de Hierro s/n,
394 39 09.
ier B.V. on behalf of the Research N
licenses/by/4.0/).1. Introduction
A growing body of literature strongly supports the involvement of
extracellular nucleotides as key messenger molecules modulating im-
portant functions at different cellular populations of the nervousetwork of Computational and Structural Biotechnology. This is an open access article
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(P2Y) receptors [4,6]. Among metabotropic P2Y nucleotide receptors,
some of them, such as P2Y2 receptors, are well characterized within
the nervous system in terms of their coupled intracellular signaling cas-
cades that promote relevant functions related to neuroprotection and
neuroregeneration [57]. In fact, correct function and expression of
P2Y2 receptor seem to be essential for a better outcome in mouse
models of neurodegenerative diseases [1,34]. In addition, P2Y1 recep-
tors also play important roles in the nervous system, being present at
very early stages of the development in radial glia, contributing to
their proliferation, migration and subsequent guidance of the cortical
neuron population [58].
P2Y13 receptor is one of the most recently cloned P2Y receptors. It
belongs, together with P2Y1 and P2Y12, to a distinct structural branch
of P2Y receptors speciﬁc for adenine diphosphate nucleotides. Likewise,
P2Y12, P2Y13 and the UDP-glucose responding P2Y14 receptors, enclose
a subfamily of Gi-coupled receptors, which differ from Gq-coupled
P2Y1 receptors. P2Y12 receptors were ﬁrst cloned and characterized as
the target of ADP-stimulated thrombus formation in platelets [24], but
they seemed not to be expressed in the brain. Therefore, the receptor re-
sponsible for abundance of Gi-linked activity mediated by ADP and
2MeSADP in brain remained unidentiﬁed until the cloning of human
and murine P2Y13 receptors, when it was recognized as the previously
known GPR-86 [7,60]. P2Y13 receptor shared sequence identity with
P2Y12 receptor, but they can be distinguished upon different pharmaco-
logical and signaling properties [7,39,40]. The identiﬁcation of the rat
P2Y13 receptor conﬁrmed the existence of this new member of the Gi-
coupled P2Y subfamily [15], which exhibited several differences with
respect to human and murine counterparts. The expression proﬁle re-
vealed that it was very abundant in the spleen as well as in the rat
brain, suggesting an important role for this receptor in both the immune
and nervous systems.
This background data prompted us to study the expression of this
kind of receptors in cellular populations of the cerebellar cortex,
where a high Gi-linked ADP activity was reported [33]. Accordingly,
during the progress of our studieswith primary cultures of rat cerebellar
astrocytes and granule neurons, we accumulated a great deal of evi-
dence involving speciﬁc ADP-mediated signaling non-attributable to
other previously characterized nucleotide receptors. These results are
covered in detail in separate sections throughout this review, in which
we describe the identiﬁcation of P2Y13 receptors in both, puriﬁed astro-
cyte and granule cell cultures, as well as their coupled signaling to main
intracellular cascades related to cell maintenance and survival.
2. Presence of Functional P2Y13 Receptors in Rat Cerebellar Astrocytes
Our studies on P2Y13 receptors began in rat puriﬁed cerebellar
astrocyte cultures, which constituted an excellentmodel to characterize
metabotropic P2Y receptor signaling. In previous works, we described
that cerebellar astrocytes expressed a great variety of metabotropic
P2Y receptors [27]. The majority of the cells co-expressed at least two
functional P2Y subtypes, P2Y1 and P2Y2/4 receptors, at that time these
receptors were activated with 2MeSATP and UTP, respectively [27].
Besides, 2MeSATP and UTP evoked calcium responseswere strongly po-
tentiated by the co-stimulation of Gs-coupled receptors co-expressed in
the same cell, such as ligands of beta-adrenoceptors, as well as by other
purinergic compounds including adenosine or the dinucleotide Ap5A
[28]. These results indicated that purinergic signaling played an impor-
tant role in these glial cells. Later on, the availability of new agonist for
ADP receptors, the non-hydrolyzable analogue, 2MeSADP, and the
identiﬁcation of new subtypes P2Y12/13 receptors, allowed us to re-
characterize P2Y1 responses in cerebellar astrocytes. We conﬁrmed
that all individual astrocytes responded to 2MeSADP stimulation with
calcium responses similar to that observed with 2MeSATP, but surpris-
ingly they exhibited a different sensitivity to the speciﬁc P2Y1 antago-
nist, MRS2179. Unexpectedly, most astrocytes exhibited 2MeSADPinduced calcium responses in the presence of the P2Y1 antagonist, and
only a small population of astrocytes, accounting only for 13% of tested
cells, did not display calcium responses in the presence of the antago-
nist, which corresponded to cells that only expressed functional P2Y1
receptors. A 38% of tested cells exhibited 2MeSADP evoked calcium re-
sponses insensitive to MRS2179 antagonism and a 49% of the cells
were partially sensitive, indicating that another ADP receptor was pres-
ent in these cells (Fig. 1A). Taking into account that the new ADP recep-
tors were Gi-coupled receptors, their presence and functionality were
investigated by analyzing the effect of ADP and 2MeSADP on cAMP pro-
duction induced by isoproterenol. These experiments were performed
in the presence ofMRS2179 and adenosine deaminase to avoid any pos-
sible interference with P2Y1 receptor or A2B adenosine receptors, also
present in these glial cells (Fig. 1B). The pharmacological proﬁles of
responses inhibiting isoproterenol-induced cAMP production, the sen-
sitivity to Pertussis Toxin and the insensitivity to P2Y12 receptor antago-
nists revealed that the functional Gi-linked ADP receptor present in
cerebellar astrocytes was a P2Y13 receptor subtype [5]. Therefore,
P2Y13 receptors were also contributing to calcium responses triggered
by 2MeSADP in rat cerebellar astrocytes, although whether they are
found as single P2Y13 receptors or assembling P2Y1/P2Y13 heterodimers
remains unclear.
To go deeply into the characterization of intracellular signaling
coupled to P2Y13 receptor stimulation in rat cerebellar astrocytes, we
checked one of the most important cross-talk signaling activated by
Gi-coupled receptors, the activation of the extracellular regulated ki-
nases (ERKs), which are members of the family of mitogen-activated
protein kinases (MAPKs) targeted by growth factor receptors. We
proved that stimulation of cerebellar astrocytes with 2MeSADP
increased phosphorylation of ERK1/2, the active form of ERKs.
2MeSADP-induced ERK activationwas transient, peaking at 5min of in-
cubation with the nucleotide and turning to basal levels one hour after
treatment. ERK activation was completely prevented by Pertussis Toxin
pre-treatment, which clearly indicated that ERK activation induced by
2MeSADP was mediated by a Gi-coupled receptor in cerebellar
astrocytes, most likely the P2Y13 receptor. In fact, the EC50 value ob-
served in ERK activation studies correlated with that obtained in exper-
iments of cAMP production inhibition (around 40 nM) (Fig. 1C and
D) [5]. Considering that P2Y1 receptors are present in a large population
of cerebellar astrocytes, we analyzed their possible contribution to
ERK activation induced by 2MeSADP. In contrast to that observed in
calcium responses, ERK activation induced by 2MeSADP was insensi-
tive to the P2Y1 receptor antagonist MRS2179, indicating that P2Y13
is exclusively mediating this response. 2MeSADP-induced ERK acti-
vation was insensitive to intracellular calcium chelation, and depen-
dent on nPKC and src-like kinase activation. When the speciﬁc P2Y13
receptor antagonist MRS2211 was released to the market, we con-
ﬁrmed that ERK activation induced by 2MeSADP in cerebellar astro-
cytes was mediated by this ADP receptor subtype [unpublished
results]. Fig. 2 summarizes the intracellular signaling triggered by
2MeSADP stimulation in rat cerebellar astrocytes. Current studies
are revealing that P2Y13-induced ERK activation also displayed pro-
tective actions against genotoxic stress in these glial cells, as de-
scribed below for granule neurons, and agrees well with data
reported in cortical astrocytes [51].
3. P2Y13 Receptor Expression in Rat Cerebellar Granule Neurons
Cerebellar granule neurons constitute the major cell population of
cerebellar cortex and have been widely employed in studies of intracel-
lular signaling cascades and mechanisms responsible for cell death and
survival. The presence of nucleotide receptors in cultured granule neu-
rons has already been reported [2], describing the co-expression of sev-
eral subtypes of both P2X and P2Y receptor families, and their variations
according to different stages of granule cell maturation in culture. Based
on intracellular calcium responses displayed by different adenine and
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Fig. 1. 2MeSADP responses in rat cerebellar astrocytes. A. 2MeSADP calcium responses in single cerebellar astrocytes. Cells loaded with fura-2 were challenged with 10 μM 2MeSADP for
30 s and the increases in theﬂuorescence ratio (F340/F380) calculated as described [5].Where indicated cellswere pre-incubatedwith 10 μMMRS2179 for 3min previous to be stimulated
with 2MeSADP in the continuous presence of the P2Y1 receptor antagonist. B. Concentration response curve obtained for the inhibition of cAMP production induced by isoproterenol. Cells
were stimulated for 3minwith 10 μM isoproterenol in the presence or absence of different 2MeSADP concentrations and the cAMP levels were determined by the enzyme-immunoassay
from Amersham. C. ERK activation induced by 2MeSADP stimulation in cerebellar astrocytes. The presence of the active form of ERK (phosphor-ERK)was detected by western blot exper-
iments from total cell lysates obtained from astrocytes, which were stimulated for 5 min with 10 μM 2MeSADP. Where indicated astrocytes were preincubated with Pertussis Toxin
(100 ng/mL, overnight), BAPTA-AM (10 μM, 30min), PDBU (200 nM, overnight) or PP2 (10 μM, 30min), previous to be stimulatedwith the nucleotide. Similar experiments were carried
out in cells pretreated with the P2Y1 receptor antagonist. The non-phosphorylated form of ERK was also detected. Panel shows the results of a representative experiment of each exper-
imental condition. D. Diagram shows the concentration response curve obtained for the ERK-activation induced by 2MeSADP in rat cerebellar astrocytes. Cells were stimulated for 5 min
with different 2MeSADP concentrations and the phosphor-ERK quantiﬁed by immunoblotting.
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Cells responding to 2MeSADP were observed between 7- and 14-DIV
(days in vitro). Among them, 40% exhibited calcium responses insensi-
tive to the extracellular calcium chelation and the P2Y1 receptor antag-
onist MRS2179. Therefore, this kind of response could be attributed to
another type of ADP-responding P2Y receptor, P2Y12 or P2Y13 subtypes
[19]. Although P2Y1, P2Y12 and P2Y13 transcripts were expressed in
granule neurons, only the P2Y13 receptor triggered intracellular calcium
signals, as described by promiscuous coupling of this receptor to G16, Gi
and Gs proteins [7,40]. Later on, the availability of speciﬁc antibodies
against P2Y12 and P2Y13 receptors conﬁrmed the presence of P2Y1 and
P2Y13 proteins in granule cells. Fig. 3A depicts the speciﬁc immunostain-
ing obtained for anti-P2Y1 and P2Y13 receptor antibodies in 10DIV gran-
ule neurons. Moreover, western blot studies revealed speciﬁc bands for
P2Y1 and P2Y13 proteins, corroborating the presence of both receptors
in granule neurons (Fig. 3B).
In order to know whether P2Y1 and P2Y13 receptors were able to
work in combination or elicit speciﬁc responses in this neuronal
model, calcium-dependent signaling coupled to the activation of both
receptors was analyzed. In this regard, we found out that only the
P2Y1 receptor mediated the phosphorylation and activation of one of
the main calcium signaling transducer, calcium calmodulin kinase II
(CaMKII). This action could be observed and quantiﬁed in both somaand neurite compartments of granule neurons and was completely
abolished by the presence of the speciﬁc P2Y1 receptor antagonist
MRS2179 [35]. Moreover, we have recently reported speciﬁc functions
for P2Y13 receptors at the level of classical pathways coupled to trophic
factors, such as ERK-MAPK and glycogen synthase kinase-3 (GSK3) sig-
naling. These evidences indicate that P2Y1 and P2Y13 receptors could be
acting independently and mediating different functions in the cerebel-
lar granule cells.
4. P2Y13 Receptors are Coupled toGSK3Signaling inGranuleNeurons
The main survival pathway present in granule neurons is the PI3K/
Akt axis, which is triggered by potent trophic signals, such as the growth
factor IGF-I and the neurotrophin BDNF [10,20,42,53]. One of the main
targets of Akt is GSK3, which is phosphorylated in Ser21/9 residues (for
α and β GSK3 isoforms, respectively) leading to the inhibition of its cat-
alytic activity [17]. An increase of GSK3 activity by expression of a con-
stitutively active form of GSK3 leads to neuronal death [20,37], whereas
trophic factors maintain high levels of phosphorylated GSK3 in order to
retain GSK3 in its inactive form [9,47]. GSK3 kinase activity is able to
amplify several stimuli that trigger the intrinsic mitochondrial-
dependent apoptotic pathway. For instance, GSK3 can phosphorylate
and transcriptionally activate key pro-apoptotic factors, such as Bax
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Fig. 2. Schematic representation of the intracellular cascades triggered by 2MeSADP stimulation in rat cerebellar astrocytes. 2MeSADP can activate both P2Y1 and P2Y13 receptors, which
are present in the majority of astrocyte population, and induce intracellular calciummobilization. 2MeSADP acting through a canonical P2Y13 receptor, via Gi protein, inhibits cAMP pro-
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family proteins and CREB transcription factor [37,41].
In cerebellar granule neurons, 2MeSADP promoted a transient
increase in GSK3 phosphorylation in a PI3K-dependent way. In
fact, 2MeSADP was also able to stimulate the phosphorylation and
activation of the upstream kinase Akt, suggesting that an ADP-
responding P2Y receptor mediated the activation of the PI3K/Akt/
GSK3 axis (Fig. 3C) [46]. The effect of 2MeSADP was sensitive to
Pertussis Toxin treatment and was not modiﬁed by intracellular calci-
um chelation, thereby indicating the implication of a Gi-coupled
receptor [46]. Additional pharmacological tools were employed to
conﬁrm this assumption, including no effect of P2Y1 and P2Y12 spe-
ciﬁc antagonists, sensitivity to P2Y13 antagonist MRS2211 (Fig. 3D),
and similar afﬁnities for ADP and 2MeSADP. Altogether, these data
pointed out to P2Y13 as the receptor responsible for 2MeSADP-
mediated effect on GSK3 signaling in granule neurons [46].
To shed some light on the physiological role played by P2Y13 nucle-
otide receptor, we analyzed some well-known substrates of GSK3. This
enzyme is involved in the regulation of several transcription factors and
modulates their function, half-life and subcellular location [17,30]. One
of the best characterized is β-catenin, a transcriptional regulator that
is normally associated to GSK3 in axin-containing multiprotein com-
plexes at the cytosol. GSK3 restricts β-catenin activation by promoting
its phosphorylation, which directs β-catenin to proteasomal degrada-
tion. The activation ofWnt signaling through frizzled receptors destabi-
lizes GSK3 protein complex and releases unphosphorylated β-catenin,
which enables it to translocate to the nuclear compartment and regulate
transcription of Tcf/Lef-1-dependent genes. This way of GSK3 inactiva-
tion is known as the canonical pathway and is different from the PI3K/
Akt-dependent pathway triggered by insulin and related growth fac-
tors. Interestingly, we demonstrated the stabilization and nuclear trans-
location of β-catenin following 2MeSADP treatment in granule neurons.
In addition, IGF-I, which potently activates the PI3K/Akt/GSK3 axis in
granule neurons, was also involved in β-catenin nuclear accumulation.
Our results evidenced the presence of a cross-talk between GSK3canonical pathway and the insulin pathway through the activation of
β-catenin, and P2Y13 receptor as a gene transcription regulator in neu-
ronal models [45]. Transcriptional activity of β-catenin in granule neu-
rons has not yet been analyzed in detail, but their functions in cell
cycle regulation, cell adhesion, migration, and survival have been
described [18] (Fig. 4).
4.1. P2Y13 Receptor Mediated Activation of the Nrf-2/HO-1 Axis in Granule
Neurons
Another interesting outcome of GSK3 signaling mediated by P2Y13
receptor in granule neurons involved the transcription factor Nrf2
(NF-R2-related factor-2). This factor is a master antioxidant regulator
that binds antioxidant response elements (AREs) and regulates the
transcription of detoxiﬁcation genes. Nrf2 activation induces expression
of several antioxidant enzymes of the so-called phase II response, such
as heme oxigenase-1 (HO-1), providing a major mechanism in cellular
defense against oxidative stress [26,32]. Nrf2 levels are low under ho-
meostatic redox conditions, and this is achieved by its binding to the
chaperone Keap-1, which retains Nrf2 at the cytosol allowing its
ubiquitination and proteasomal degradation [44]. Another way of Nrf2
regulation involves its phosphorylation and translocation to the nuclear
compartment. Similar towhatwas described for β-catenin, GSK3 acts as
a negative regulator of Nrf2, which promotes Nrf2 phosphorylation and
degradation restricting its transcriptional activity over inducible genes
[49,50]. Any extracellular stimuli that induce GSK3 inactivation have
the ability to stabilize and increase Nrf2 function. In the experimental
model of granule neurons, stimulation of M1 acetylcholine Gq-coupled
receptor activates PKC-dependent GSK3 phosphorylation that induces
activation of Nrf2 and the expression of one of its target genes, heme
oxigenase-1 [14].
In collaboration with Cuadrado's group, we demonstrated for the
ﬁrst time the coupling of a Gi-coupled receptor to the Nrf2/HO-1 path-
way, which was attributable to P2Y13 nucleotide receptor activation.
The stimulation of granule neurons with 2MeSADP led to speciﬁc
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oxigenase-1, which required long incubation periods from 3 to 6 h. In
addition, both Nrf2 and HO-1 expressions were in agreement with the
pharmacological proﬁle of a P2Y13 receptor response and were depen-
dent on 2MeSADP-evoked inhibition of GSK3 signaling. In line with
this, induction of antioxidant response elements (AREs) from the HO-
1 promoter was conﬁrmed by luciferase assays in granule neurons and
in neuroblastoma N2A cells ectopically expressing hP2Y13 receptors
[13] (Fig. 4).
The activation of this potent antioxidant defense mechanism by
2MeSADP protected granule neurons against ROS production and apo-
ptosis induced by treatment with hydrogen peroxide. Both actions
were dependent on HO-1 expression, as they were abolished in the
presence of the HO-1 inhibitor protoporfyrin (SnPP). Similarly, the
coupling of P2Y13 nucleotide receptor to the Nrf2/HO-1 axis was further
reproduced in mouse granule cell cultures. As expected, in cultures
obtained from Nrf2 knock-out mice (Nrf-2−/−), 2MeSADP failed
to elicit any HO-1 expression and protection against oxidative stress
[13] (Fig. 4).
This work supported the ﬁrst evidence of Nrf2/HO-1 axis regulation
by a nucleotide receptor that linked it directly to neuroprotection. Otherexamples of protection against oxidative stress were provided by
cortical astrocytes, in which other ADP-responding receptor, P2Y1, was
responsible for the survival effect through the expression of oxidore-
ductase genes involved in antioxidant actions [51,52].
5. P2Y13 Receptor Mediated Signaling Through ERK1/2-MAPK in
Granule Neurons
Ongoing with this line of work, we next investigated other signaling
cascades of key relevance in granule neurons. ERK proteins are directly
involved in cell homeostasismaintained by trophic factors, such as IGF-I,
GDF-15 and BDNF. These factors are coupled to ERK1/2 activation in a
transient way, through a dual phosphorylation at Thr and Tyr residues
by the upstreamMAP kinase kinase-1 (MEK1). This signaling route con-
tributes to survival promoting effects of trophic factors against different
kinds of apoptotic stimuli, such as trophic withdrawal, exposure to
excitotoxic glutamate concentrations or genotoxic stress [21,22,53].
Looking for a coincident role with growth factors it was not surpris-
ing toﬁnd ERK1/2 activation by nucleotidic agonists in granule neurons.
Among them, 2MeSADPwas able to induce transient ERK1/2 phosphor-
ylation and activation, which peaked at 15 min of stimulation period.
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of the transcriptional targets,β-catenin andNrf2.β-catenin regulates transcription of Tcf/Lef-1-dependent genes involved in survival, differentiation and cell cycle dynamics. The transcrip-
tion factor Nrf2 activates ARE-dependent genes involved in antioxidant cell response, such as heme oxigenase-1 (HO-1). Activation of the Nrf2/HO-1 axis in response to 2MeSADP
stimulation in granule neurons functions as an important antioxidant defense mechanism that protects against ROS production and oxidative stress-induced apoptosis evoked by
treatment with H2O2.
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found for GSK3, since 2MeSADP-mediated ERK1/2 activation resulted
to be a Gi-coupled-dependent event and also required intact PI3K activ-
ity. In addition, 2MeSADP-dependent ERK1/2 activation was only sensi-
tive to the P2Y13 receptor antagonist MRS2211, once again supporting
the role of P2Y13 as the receptor responsible for ERK1/2 signaling elicit-
ed by 2MeSADP in this cellular model. These results gave evidence that
the PI3K activity was essential for P2Y13 receptor function in granule
neurons acting as an upstream effector of both ERK1/2 and GSK3
signaling.
Similarly, P2Y13 receptor activation partially protected granule neu-
rons against glutamate excitotoxicity-evoked apoptosis. This survival
promoting effect was dependent on the activity of CREB transcription
factor, one of themain targets of ERK1/2-mediated signaling in neuronal
models. Indeed, CREB phosphorylation was parallel to ERK1/2 phos-
phorylation following P2Y13 receptor activation. In addition, CREB
pharmacological inhibition, not only abolished any protective effect
elicited by P2Y13 receptors, but also severely compromised cell survival.
These results agree with the role of CREB as the key regulator of the ex-
pression of genes required for long-term neuronal plasticity and sup-
pression of apoptosis, such as the anti-apoptotic protein Bcl-2 (Fig. 5).
ERK1/2/CREB-dependent survival pathway was also activated by the
neurotrophin BDNF acting on TrkB receptors in granule neurons. In-
deed, BDNF potently promoted ERK1/2 phosphorylation until 1 h after
stimulation. In agreement with this higher level of ERK1/2 activation,
BDNF behaved as a stronger effector supporting cell survival in condi-
tions of excitotoxic glutamate concentrations [45].5.1. Dual Speciﬁcity Protein Phosphatase 2, DUSP2, is an Intracellular Target
of P2Y13 Receptor in Granule Neurons
Recently we have identiﬁed a new target of P2Y13 receptor mediat-
ed-ERK1/2 signaling in granule neurons, the protein phosphatase
DUSP2. This is a member of the family of dual speciﬁcity phosphatases,
which presents the ability to dephosphorylate both Thr/Ser and Tyr res-
idues of MAP kinases [12,48].
Our ﬁrst knowledge of dual protein phosphatases came fromprevious
gene expression studies performed by a microarray analysis in granule
neurons stimulated with 2MeSADP. Functional analysis revealed several
clusters of over-represented genes related to protein phosphatase activi-
ty. It was noticeable that the concurrence of several phosphatases
belonged to the family of DUSP phosphatases, particularly the protein
DUSP2. QPCR experiments validated microarray results and conﬁrmed
that stimulation of granule neuronswith 2MeSADP induces the transcrip-
tion of dusp2 gene within a time course that was characteristic of an im-
mediate early gene (IEG). As expected, dusp2 expression was abolished
by the inhibition of both ERK signaling and PI3K activity, and by the
P2Y13 speciﬁc antagonist MRS2211. These data conﬁrmed that dusp2
genewas under the regulation of PI3K/ERK1/2mediated signaling stimu-
lated by P2Y13 receptors in granule neurons [43].
DUSP2 belongs to a subfamily of dual speciﬁcity protein phospha-
tases that are speciﬁc for MAP kinases, and they are termed typical
DUSPs orMKPs (MAPK phosphatases). TheMKPs constitute a structural
distinct group of enzymes that can be classiﬁed in different subgroups
based on their substrate speciﬁcity and subcellular distribution. The
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Fig. 5. P2Y13 receptors activate ERK1/2 signaling and promote survival in granule neurons. P2Y13 receptor stimulation by the agonist 2MeSADP triggers ERK1/2 signaling in a PI3K-depen-
dentway. Among different ERK1/2 signaling substrates, the transcription factor CREB becomes activated by phosphorylation inparallelwith ERK1/2. CREB regulates expression of different
genes, such as the anti-apoptotic Bcl-2, and can explain the survival promoting effect of 2MeSADP stimulation against apoptosis induced by excitotoxic concentrations of glutamate. In
addition, P2Y13 receptor participates in cross-regulation of MAPK signaling in granule neurons. It promotes transcriptional expression of dual speciﬁcity protein phosphatase 2
(DUSP2) dependent on ERK1/2 signaling. Rise in DUSP2 protein levels is responsible of recovering basal levels of unphosphorylated form of stress related p38-MAPK, which had been ac-
tivated during genotoxic stress induced by cisplatin treatment. Finally, restoring DUSP2 activity contributes to maintain cell survival in conditions of cisplatin-induced cytotoxicity.
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wards different types of MAPKs, although with some preference for
the stress related kinases, p38 and JNK, being DUSP1 and DUPSP2 the
most representative ones. Other types of DUSPs are constitutive and ex-
clusively found at the cytoplasmic compartment, as is the case of the
ERK1/2 selective phosphatase, DUSP6. Concerning their physiological
signiﬁcance, MKPs are emerging as key regulators of both the intensity
and duration ofMAPK signaling. Along this line, defects in DUSP expres-
sion or activity are always associated to over-activation of MAP kinases
for long-periods of time, and this usually occurs during the exposition to
several kinds of stress-inducing stimuli [12,31,48].
In agreement with that, we induced genotoxic stress in granule neu-
rons by exposure to cisplatin, which is a cytotoxic drug commonly used
in chemotherapy with important neurotoxic side effects. Cisplatin expo-
sure promoted increase over time of the phosphorylated form of the
stress MAPK, p38, which runs in parallel with the progressive decrease
of DUSP2 protein levels. In these conditions, a previous activation of
P2Y13 receptors had the effect of increasing DUSP2 protein expression
and restoring basal phosphorylation levels of p38 (Fig. 5). As expected,
P2Y13 receptor-mediated dephosphorylating effect on p38 as well as its
prosurvival actions during cisplatin treatment were prevented by both
P2Y13 speciﬁc antagonistMRS2211 and the inhibitor of tyrosine phospha-
tases orthovanadate. Therefore, P2Y13 activity on DUSP2 expression also
contributed to neuroprotection against genotoxic stress [43] (Fig. 5).
6. Summary and Outlook
Thiswork covers thepresent knowledge andunderstanding of P2Y13
receptor function in cell populations of the cerebellar cortex. In previousstudies, P2Y1 expression and speciﬁc functions have already been de-
scribed in both cerebellar astrocytes and granule neurons [27,5,35].
However, some ADP-activated signaling properties still remained un-
clear, as theywere attributable to Gi-coupled receptor and not sensitive
to P2Y1 receptor inhibition. The availability of new pharmacological
tools, such as P2Y13 speciﬁc antagonist MRS2211, as well as speciﬁc an-
tibodies, allowed us to ascribe these functions to the presence of P2Y13
receptors in both astrocytes and granule neurons.
According to the results presented here, it can be presumed that
P2Y1 and P2Y13 receptors can trigger different intracellular routes, me-
diating diverse and independent functions in astrocytes and granule
neurons. It is noteworthy that in both cell populations P2Y1 and P2Y13
receptors induce intracellular calcium mobilization. However, ERK1/2
signaling is speciﬁcally a Gi-coupled event not covered by P2Y1
receptor, indicating that trophic functions are mainly linked to P2Y13
receptors. Importantly, P2Y13 receptors couple ADP to neuroprotection
in the neuronal model of granule cells. In this sense, they lead to the ac-
tivation of transcription factors directly involved in the regulation of
survival promoting genes, such as the ERK1/2-dependent target CREB.
In addition, P2Y13 receptors also trigger the main survival PI3K/Akt/
GSK3 pathway in granule neurons that is typically activated by trophic
factors, activating the antioxidant defense response Nrf2/HO-1 axis
that protects against oxidative stress. Therefore, P2Y13 receptors
promote neuroprotection and increase resistance of granule cells to
different kinds of apoptotic stimuli by activating both signaling
mechanisms. Although extracellular ADP is not as potent as growth
factors and neurotrophins in the activation of granule cell signaling
and survival, it can play a pivotal role in conditions of limiting trophic
factor availability.
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tors have been obtained from primary cultures and special caution is
needed before their extrapolation to in vivo situation, granule neuron
cultures has been accepted as an excellent in vitromodel to study pro-
cesses related to neuronal survival and differentiation. Indeed, dissoci-
ated granule cells exhibit the same dependence on trophic supply and
synaptic activity to that observed during in vivo development and mi-
gration along the cerebellar cortex. Therefore, as it happens with other
factors, such as IGF-I and BDNF, nucleotide receptors could exert similar
functions in vivo. Evidences exist of purinergic tone at cerebellar cortex
that can account for physiological responses implying nucleotide recep-
tors. In addition, the release of high amounts of ATP after damaging or
toxic conditions can produce extracellular ADP nucleotide that fully ac-
tivates P2Y1 and P2Y13 receptors [8].
In other cell populations of central nervous system, P2Y1 as well as
P2Y13 receptors play a pivotal role in neuronal differentiation and axonal
elongation [11,59]. In addition, in the spinal cord primary neuronal cul-
tures, both P2Y1 and P2Y13 receptors coordinate opposite regulation of
glycine transport activity providing inhibition of neuronal GLYT2 and
stimulation of glial GLYT1. This regulation involves a paracrine mecha-
nism dependent on nitric oxide production and protein kinase G (PKG)
activation, and supports a role of these receptors in nociception [29].
Concerning the physiological role of P2Y13 receptor in the non-
neural tissues, it remains largely unexplored. In the red blood cells,
ADP-responding P2Y13 receptor provides a negative feedback mecha-
nism of ATP release to regulate plasma ATP levels [56]. P2Y13 receptor
is also involved in the mast cell degranulation and release of antigen-
induced release of hexosaminidase, whereas co-expressed P2Y1 recep-
tor is responsible for intracellular calcium mobilization in response to
ADP [16]. Moreover, P2Y13 receptor is involved in the regulation of he-
patic HDL endocytosis through downstream signaling involving small
GTPase RhoA and its effector ROCK1 [38]. Studies in P2Y13 knock-out
mice revealed that they are resistant to high cholesterol diet and accen-
tuated impaired hepatobiliary reverse cholesterol transport [36]. There-
fore this work is the basis to consider pharmacological approaches to
regulate HDLmetabolism in dyslipidemias, one of themajor risk factors
of atherosclerosis and cardiovascular diseases. The P2Y13 activator AR-
C69931MX is now under clinical development to increase cholesterol
catabolism by the liver [25].
Conversely, P2Y13 receptor inhibition in pancreatic β-cell line is able
to activate insulin release through PI3K-dependent signaling and pro-
motes survival on pancreatic cells [3,54]. In this line, the pro-apoptotic
role of P2Y13 receptors is also observed in the enteric nervous system,
where genetic depletion of P2Y13 receptor resulted protective against
high-fat diet neuronal loss [55].
The present work summarizes the pivotal role of P2Y13 receptors in
the maintenance of neuronal survival against different harmful stimuli
that compromise cell viability. Of relevance is the novel mechanism of
action described for P2Y13 receptors in granule neurons that link them
to protein phosphatase regulation. This study describes for the ﬁrst
time the participation of P2Y13 receptors in negative feedback regula-
tion of MAP kinase signaling in a neuronal model. Once again, nucleo-
tides behave similarly than trophic factors, which limit their own
mitogenic signaling through the expression of different types of DUSP
proteins and contribute to granule cell survival. Further studies will be
necessary to determine the physiological relevance of the regulation
of different types of dual protein phosphatases andwhether they consti-
tute a general signalingmechanism for other types of nucleotide recep-
tors. P2Y-mediated regulation of protein phosphatases had been
previously reported in cortical astrocytes under oxidative stress. These
apoptotic conditions also evoked sustained ERK1/2 phosphorylation.
The expression of protein tyrosine phosphatases (PTPs) induced by
P2Y1 receptors was proposed as the mechanism responsible for restor-
ing the basal levels of ERK1/2 phosphorylated form and promoting cell
survival [51]. Thus, protein phosphatases could be considered as novel
targets for nucleotide receptor signaling that link them to MAP kinasehomeostasis and survival in different cellular models. Considering that
MAPK activation can be critical in conditions related to aging and neuro-
degenerative diseases, DUSP proteins emerge as promising targets to re-
store signaling mechanisms that became deregulated in these physio-
pathological conditions [23]. Further efforts are required to improve
the knowledge of protein phosphatases, their regulation and activation
pathways, in order to identify new pharmacological approaches.
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